世界のがん生物学的療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cancer Biological Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1062 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、がん生物学的療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、ワクチン、癌増殖阻害剤、血球増殖因子）、用途別市場規模（病院、診断研究所、研究・学術研究所、製薬・バイオテクノロジー企業）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん生物学的療法の市場動向 ・企業の競争状況、市場シェア ・がん生物学的療法の種類別市場規模（モノクローナル抗体、ワクチン、癌増殖阻害剤、血球増殖因子） ・がん生物学的療法の用途別市場規模（病院、診断研究所、研究・学術研究所、製薬・バイオテクノロジー企業） ・がん生物学的療法の北米市場規模2016-2027（アメリカ、カナダ） ・がん生物学的療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん生物学的療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん生物学的療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん生物学的療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ELI Lilly、Sanofi、Merck、Bayer、Roche、Novartis International、Pfizer、Bristol-Myers Squibb、Seattle Genetics、Amgen、Takeda Pharmaceuticals、GlaxoSmithKline、Spectrum Pharmaceuticals、Celgene Corporation、AstraZeneca, Plc.、Otsuka、Eisai、Abbvie、Incyte） ・結論

Market Analysis and Insights: Global Cancer Biological Therapy Market
The global Cancer Biological Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Biological Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Biological Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Biological Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Biological Therapy market.

Global Cancer Biological Therapy Scope and Market Size
Cancer Biological Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Biological Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors

Segment by Application
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Bayer
Roche
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biological Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Vaccines
1.2.4 Cancer Growth Blockers
1.2.5 Blood Cell Growth Factors
1.3 Market by Application
1.3.1 Global Cancer Biological Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research & Academic Laboratories
1.3.5 Pharmaceutical & Biotechnology Companies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer Biological Therapy Market Perspective (2016-2027)
2.2 Cancer Biological Therapy Growth Trends by Regions
2.2.1 Cancer Biological Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Biological Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Biological Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Biological Therapy Industry Dynamic
2.3.1 Cancer Biological Therapy Market Trends
2.3.2 Cancer Biological Therapy Market Drivers
2.3.3 Cancer Biological Therapy Market Challenges
2.3.4 Cancer Biological Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Biological Therapy Players by Revenue
3.1.1 Global Top Cancer Biological Therapy Players by Revenue (2016-2021)
3.1.2 Global Cancer Biological Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Biological Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Biological Therapy Revenue
3.4 Global Cancer Biological Therapy Market Concentration Ratio
3.4.1 Global Cancer Biological Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biological Therapy Revenue in 2020
3.5 Cancer Biological Therapy Key Players Head office and Area Served
3.6 Key Players Cancer Biological Therapy Product Solution and Service
3.7 Date of Enter into Cancer Biological Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Biological Therapy Breakdown Data by Type
4.1 Global Cancer Biological Therapy Historic Market Size by Type (2016-2021)
4.2 Global Cancer Biological Therapy Forecasted Market Size by Type (2022-2027)

5 Cancer Biological Therapy Breakdown Data by Application
5.1 Global Cancer Biological Therapy Historic Market Size by Application (2016-2021)
5.2 Global Cancer Biological Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cancer Biological Therapy Market Size (2016-2027)
6.2 North America Cancer Biological Therapy Market Size by Type
6.2.1 North America Cancer Biological Therapy Market Size by Type (2016-2021)
6.2.2 North America Cancer Biological Therapy Market Size by Type (2022-2027)
6.2.3 North America Cancer Biological Therapy Market Size by Type (2016-2027)
6.3 North America Cancer Biological Therapy Market Size by Application
6.3.1 North America Cancer Biological Therapy Market Size by Application (2016-2021)
6.3.2 North America Cancer Biological Therapy Market Size by Application (2022-2027)
6.3.3 North America Cancer Biological Therapy Market Size by Application (2016-2027)
6.4 North America Cancer Biological Therapy Market Size by Country
6.4.1 North America Cancer Biological Therapy Market Size by Country (2016-2021)
6.4.2 North America Cancer Biological Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cancer Biological Therapy Market Size (2016-2027)
7.2 Europe Cancer Biological Therapy Market Size by Type
7.2.1 Europe Cancer Biological Therapy Market Size by Type (2016-2021)
7.2.2 Europe Cancer Biological Therapy Market Size by Type (2022-2027)
7.2.3 Europe Cancer Biological Therapy Market Size by Type (2016-2027)
7.3 Europe Cancer Biological Therapy Market Size by Application
7.3.1 Europe Cancer Biological Therapy Market Size by Application (2016-2021)
7.3.2 Europe Cancer Biological Therapy Market Size by Application (2022-2027)
7.3.3 Europe Cancer Biological Therapy Market Size by Application (2016-2027)
7.4 Europe Cancer Biological Therapy Market Size by Country
7.4.1 Europe Cancer Biological Therapy Market Size by Country (2016-2021)
7.4.2 Europe Cancer Biological Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cancer Biological Therapy Market Size (2016-2027)
8.2 Asia-Pacific Cancer Biological Therapy Market Size by Type
8.2.1 Asia-Pacific Cancer Biological Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Biological Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Biological Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Biological Therapy Market Size by Application
8.3.1 Asia-Pacific Cancer Biological Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Biological Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Biological Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Biological Therapy Market Size by Region
8.4.1 Asia-Pacific Cancer Biological Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Biological Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cancer Biological Therapy Market Size (2016-2027)
9.2 Latin America Cancer Biological Therapy Market Size by Type
9.2.1 Latin America Cancer Biological Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Biological Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Biological Therapy Market Size by Type (2016-2027)
9.3 Latin America Cancer Biological Therapy Market Size by Application
9.3.1 Latin America Cancer Biological Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Biological Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Biological Therapy Market Size by Application (2016-2027)
9.4 Latin America Cancer Biological Therapy Market Size by Country
9.4.1 Latin America Cancer Biological Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Biological Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer Biological Therapy Market Size (2016-2027)
10.2 Middle East & Africa Cancer Biological Therapy Market Size by Type
10.2.1 Middle East & Africa Cancer Biological Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Biological Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Biological Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Biological Therapy Market Size by Application
10.3.1 Middle East & Africa Cancer Biological Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Biological Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Biological Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Biological Therapy Market Size by Country
10.4.1 Middle East & Africa Cancer Biological Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Biological Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 ELI Lilly
11.1.1 ELI Lilly Company Details
11.1.2 ELI Lilly Business Overview
11.1.3 ELI Lilly Cancer Biological Therapy Introduction
11.1.4 ELI Lilly Revenue in Cancer Biological Therapy Business (2016-2021)
11.1.5 ELI Lilly Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Cancer Biological Therapy Introduction
11.2.4 Sanofi Revenue in Cancer Biological Therapy Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Cancer Biological Therapy Introduction
11.3.4 Merck Revenue in Cancer Biological Therapy Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Cancer Biological Therapy Introduction
11.4.4 Bayer Revenue in Cancer Biological Therapy Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Cancer Biological Therapy Introduction
11.5.4 Roche Revenue in Cancer Biological Therapy Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Novartis International
11.6.1 Novartis International Company Details
11.6.2 Novartis International Business Overview
11.6.3 Novartis International Cancer Biological Therapy Introduction
11.6.4 Novartis International Revenue in Cancer Biological Therapy Business (2016-2021)
11.6.5 Novartis International Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Cancer Biological Therapy Introduction
11.7.4 Pfizer Revenue in Cancer Biological Therapy Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Cancer Biological Therapy Introduction
11.8.4 Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Details
11.9.2 Seattle Genetics Business Overview
11.9.3 Seattle Genetics Cancer Biological Therapy Introduction
11.9.4 Seattle Genetics Revenue in Cancer Biological Therapy Business (2016-2021)
11.9.5 Seattle Genetics Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Cancer Biological Therapy Introduction
11.10.4 Amgen Revenue in Cancer Biological Therapy Business (2016-2021)
11.10.5 Amgen Recent Development
11.11 Takeda Pharmaceuticals
11.11.1 Takeda Pharmaceuticals Company Details
11.11.2 Takeda Pharmaceuticals Business Overview
11.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Introduction
11.11.4 Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2016-2021)
11.11.5 Takeda Pharmaceuticals Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Cancer Biological Therapy Introduction
11.12.4 GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2016-2021)
11.12.5 GlaxoSmithKline Recent Development
11.13 Spectrum Pharmaceuticals
11.13.1 Spectrum Pharmaceuticals Company Details
11.13.2 Spectrum Pharmaceuticals Business Overview
11.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Introduction
11.13.4 Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2016-2021)
11.13.5 Spectrum Pharmaceuticals Recent Development
11.14 Celgene Corporation
11.14.1 Celgene Corporation Company Details
11.14.2 Celgene Corporation Business Overview
11.14.3 Celgene Corporation Cancer Biological Therapy Introduction
11.14.4 Celgene Corporation Revenue in Cancer Biological Therapy Business (2016-2021)
11.14.5 Celgene Corporation Recent Development
11.15 AstraZeneca, Plc.
11.15.1 AstraZeneca, Plc. Company Details
11.15.2 AstraZeneca, Plc. Business Overview
11.15.3 AstraZeneca, Plc. Cancer Biological Therapy Introduction
11.15.4 AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2016-2021)
11.15.5 AstraZeneca, Plc. Recent Development
11.16 Otsuka
11.16.1 Otsuka Company Details
11.16.2 Otsuka Business Overview
11.16.3 Otsuka Cancer Biological Therapy Introduction
11.16.4 Otsuka Revenue in Cancer Biological Therapy Business (2016-2021)
11.16.5 Otsuka Recent Development
11.17 Eisai
11.17.1 Eisai Company Details
11.17.2 Eisai Business Overview
11.17.3 Eisai Cancer Biological Therapy Introduction
11.17.4 Eisai Revenue in Cancer Biological Therapy Business (2016-2021)
11.17.5 Eisai Recent Development
11.18 Abbvie
11.18.1 Abbvie Company Details
11.18.2 Abbvie Business Overview
11.18.3 Abbvie Cancer Biological Therapy Introduction
11.18.4 Abbvie Revenue in Cancer Biological Therapy Business (2016-2021)
11.18.5 Abbvie Recent Development
11.18 Incyte
.1 Incyte Company Details
.2 Incyte Business Overview
.3 Incyte Cancer Biological Therapy Introduction
.4 Incyte Revenue in Cancer Biological Therapy Business (2016-2021)
.5 Incyte Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cancer Biological Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Vaccines
Table 4. Key Players of Cancer Growth Blockers
Table 5. Key Players of Blood Cell Growth Factors
Table 6. Global Cancer Biological Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Biological Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Biological Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cancer Biological Therapy Market Share by Regions (2016-2021)
Table 10. Global Cancer Biological Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cancer Biological Therapy Market Share by Regions (2022-2027)
Table 12. Cancer Biological Therapy Market Trends
Table 13. Cancer Biological Therapy Market Drivers
Table 14. Cancer Biological Therapy Market Challenges
Table 15. Cancer Biological Therapy Market Restraints
Table 16. Global Cancer Biological Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cancer Biological Therapy Market Share by Players (2016-2021)
Table 18. Global Top Cancer Biological Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biological Therapy as of 2020)
Table 19. Ranking of Global Top Cancer Biological Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cancer Biological Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Biological Therapy Product Solution and Service
Table 23. Date of Enter into Cancer Biological Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Biological Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cancer Biological Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Cancer Biological Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cancer Biological Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cancer Biological Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cancer Biological Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Cancer Biological Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cancer Biological Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cancer Biological Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cancer Biological Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cancer Biological Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cancer Biological Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cancer Biological Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cancer Biological Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cancer Biological Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cancer Biological Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cancer Biological Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cancer Biological Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cancer Biological Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cancer Biological Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Biological Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Biological Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Biological Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Biological Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Biological Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cancer Biological Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Biological Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cancer Biological Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Biological Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cancer Biological Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Biological Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cancer Biological Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Biological Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Biological Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Biological Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Biological Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Biological Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cancer Biological Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. ELI Lilly Company Details
Table 64. ELI Lilly Business Overview
Table 65. ELI Lilly Cancer Biological Therapy Product
Table 66. ELI Lilly Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 67. ELI Lilly Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Cancer Biological Therapy Product
Table 71. Sanofi Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Cancer Biological Therapy Product
Table 76. Merck Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 77. Merck Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Cancer Biological Therapy Product
Table 81. Bayer Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Cancer Biological Therapy Product
Table 86. Roche Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. Novartis International Company Details
Table 89. Novartis International Business Overview
Table 90. Novartis International Cancer Biological Therapy Product
Table 91. Novartis International Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 92. Novartis International Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Cancer Biological Therapy Product
Table 96. Pfizer Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Bristol-Myers Squibb Company Details
Table 99. Bristol-Myers Squibb Business Overview
Table 100. Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 101. Bristol-Myers Squibb Recent Development
Table 102. Seattle Genetics Company Details
Table 103. Seattle Genetics Business Overview
Table 104. Seattle Genetics Cancer Biological Therapy Product
Table 105. Seattle Genetics Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 106. Seattle Genetics Recent Development
Table 107. Amgen Company Details
Table 108. Amgen Business Overview
Table 109. Amgen Cancer Biological Therapy Product
Table 110. Amgen Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 111. Amgen Recent Development
Table 112. Takeda Pharmaceuticals Company Details
Table 113. Takeda Pharmaceuticals Business Overview
Table 114. Takeda Pharmaceuticals Cancer Biological Therapy Product
Table 115. Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 116. Takeda Pharmaceuticals Recent Development
Table 117. GlaxoSmithKline Company Details
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Cancer Biological Therapy Product
Table 120. GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 121. GlaxoSmithKline Recent Development
Table 122. Spectrum Pharmaceuticals Company Details
Table 123. Spectrum Pharmaceuticals Business Overview
Table 124. Spectrum Pharmaceuticals Cancer Biological Therapy Product
Table 125. Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 126. Spectrum Pharmaceuticals Recent Development
Table 127. Celgene Corporation Company Details
Table 128. Celgene Corporation Business Overview
Table 129. Celgene Corporation Cancer Biological Therapy Product
Table 130. Celgene Corporation Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 131. Celgene Corporation Recent Development
Table 132. AstraZeneca, Plc. Company Details
Table 133. AstraZeneca, Plc. Business Overview
Table 134. AstraZeneca, Plc. Cancer Biological Therapy Product
Table 135. AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 136. AstraZeneca, Plc. Recent Development
Table 137. Otsuka Company Details
Table 138. Otsuka Business Overview
Table 139. Otsuka Cancer Biological Therapy Product
Table 140. Otsuka Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 141. Otsuka Recent Development
Table 142. Eisai Company Details
Table 143. Eisai Business Overview
Table 144. Eisai Cancer Biological Therapy Product
Table 145. Eisai Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 146. Eisai Recent Development
Table 147. Abbvie Company Details
Table 148. Abbvie Business Overview
Table 149. Abbvie Cancer Biological Therapy Product
Table 150. Abbvie Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 151. Abbvie Recent Development
Table 152. Incyte Company Details
Table 153. Incyte Business Overview
Table 154. Incyte Cancer Biological Therapy Product
Table 155. Incyte Revenue in Cancer Biological Therapy Business (2016-2021) & (US$ Million)
Table 156. Incyte Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Biological Therapy Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Vaccines Features
Figure 4. Cancer Growth Blockers Features
Figure 5. Blood Cell Growth Factors Features
Figure 6. Global Cancer Biological Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Research & Academic Laboratories Case Studies
Figure 10. Pharmaceutical & Biotechnology Companies Case Studies
Figure 11. Cancer Biological Therapy Report Years Considered
Figure 12. Global Cancer Biological Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cancer Biological Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cancer Biological Therapy Market Share by Regions: 2020 VS 2027
Figure 15. Global Cancer Biological Therapy Market Share by Regions (2022-2027)
Figure 16. Global Cancer Biological Therapy Market Share by Players in 2020
Figure 17. Global Top Cancer Biological Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biological Therapy as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cancer Biological Therapy Revenue in 2020
Figure 19. Global Cancer Biological Therapy Revenue Market Share by Type (2016-2021)
Figure 20. Global Cancer Biological Therapy Revenue Market Share by Type (2022-2027)
Figure 21. North America Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cancer Biological Therapy Market Share by Type (2016-2027)
Figure 23. North America Cancer Biological Therapy Market Share by Application (2016-2027)
Figure 24. North America Cancer Biological Therapy Market Share by Country (2016-2027)
Figure 25. United States Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cancer Biological Therapy Market Share by Type (2016-2027)
Figure 29. Europe Cancer Biological Therapy Market Share by Application (2016-2027)
Figure 30. Europe Cancer Biological Therapy Market Share by Country (2016-2027)
Figure 31. Germany Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cancer Biological Therapy Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cancer Biological Therapy Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cancer Biological Therapy Market Share by Region (2016-2027)
Figure 41. China Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cancer Biological Therapy Market Share by Type (2016-2027)
Figure 49. Latin America Cancer Biological Therapy Market Share by Application (2016-2027)
Figure 50. Latin America Cancer Biological Therapy Market Share by Country (2016-2027)
Figure 51. Mexico Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cancer Biological Therapy Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cancer Biological Therapy Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cancer Biological Therapy Market Share by Country (2016-2027)
Figure 57. Turkey Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cancer Biological Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. ELI Lilly Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 65. Novartis International Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 68. Seattle Genetics Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 69. Amgen Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 70. Takeda Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 71. GlaxoSmithKline Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 72. Spectrum Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 73. Celgene Corporation Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 74. AstraZeneca, Plc. Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 75. Otsuka Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 76. Eisai Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 77. Abbvie Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 78. Incyte Revenue Growth Rate in Cancer Biological Therapy Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

---